Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Efficacy of PF-00915275 in Type 2 Diabetes
NCT00427401Phase 2Terminated
- Sponsor
- Pfizer
- Start
- Feb 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of PF-00915275 in type 2 diabetes mellitus (T2DM), sponsored by Pfizer. Started Feb 2007; status: terminated.
02
Drugs
PF-00915275
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00427401.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00427401.